Holen Sie sich die Stockscreener-App
25.48
0.75%
0.19
Handel nachbörslich:
25.46
-0.02
-0.08%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Pfizer Inc Aktie (PFE) Neueste Nachrichten
Unusual Options Activity in Pfizer: 2 Strategies Traders Are Jumping On - Barchart.com
Zeno names Dana Gandsman global head of health, wellness - Medical Marketing and Media
Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026 - Finviz
Prediction: 2 Healthcare Stocks That Will Be Worth More Than Pfizer by the End of 2026 - The Motley Fool
Pfizer in pact with Madrigal for MASH drug (MDGL:NASDAQ) - Seeking Alpha
Madrigal licenses Pfizer’s DGAT-2 inhibitor to expand MASH pipeline - Investing.com
Madrigal licenses Pfizer’s DGAT-2 inhibitor to expand MASH pipeline By Investing.com - Investing.com India
Pharmacosmos establishes Canadian office – will collaborate on sales with Pfizer - medwatch.com
Pfizer partners Gordian Bio to probe new obesity targets - The Pharma Letter
What Could Send Pfizer Stock Soaring - Trefis
What Could Rocket Pfizer Stock to New Heights - Trefis
How Pfizer’s AI and Precision Oncology Deals At Pfizer (PFE) Have Changed Its Investment Story - Yahoo Finance
Setup Watch: Why Pfizer Inc. stock is favored by top institutionsQuarterly Risk Review & Weekly High Return Forecasts - ulpravda.ru
Citi Keeps Their Hold Rating on Pfizer (PFE) - The Globe and Mail
What margin trends mean for Pfizer Inc. stockExit Point & Fast Moving Stock Watchlists - ulpravda.ru
Pfizer Turns To AI Where Drug Risk Is Highest - Yahoo Finance
Pfizer Partners with Boltz to Use AI in Drug Discovery - TradingView — Track All Markets
Want Over $2,000 in Dividends Each Year? Invest $12,000 Each Into These 3 Stocks - Finviz
How Pfizer Inc. stock performs in high volatility marketsWeekly Profit Summary & Momentum Based Trading Ideas - ulpravda.ru
Boltz and Pfizer Announce Strategic Collaboration to Develop and Deploy Biomolecular Ai Foundation Models - MarketScreener
Pfizer stock price today: PFE ticks up after 340B court block as drug-pricing scrutiny returns - TechStock²
Pfizer, Boltz Launch Collaboration to Develop Biomolecular AI Foundation Models - MarketScreener
Pfizer, Astellas Report Positive Phase 3 Trial Results for PADCEV Combination in Bladder Cancer Treatment - Insider Monkey
Boltz and Pfizer Announce Strategic Collaboration to Develop and Deploy State-of-the-Art Biomolecular AI Foundation Models - PR Newswire
KRAS Inhibitors Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight | Pfizer, Roche, Chugai, Genentech, Revolution Medicines, Eli Lilly, Merck, Taiho, Astex Pharma, Elicio - Barchart.com
PFIZER INC : Berenberg remains Neutral - MarketScreener
Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity - Business Wire
Does Pfizer (PFE) Offer Long Term Value After A 36% Three Year Share Price Slide - simplywall.st
Pfizer (NYSE:PFE) Has Announced A Dividend Of $0.43 - simplywall.st
Pfizer's (NYSE:PFE) Dividend Will Be $0.43 - Yahoo Finance
Pfizer's Stock Just Dropped 6%. Can the Pharmaceutical Giant Bounce Back in 2026? - Nasdaq
Pneumococcal Vaccines Market to Boom Worldwide By 2026-2033 | - openPR.com
Is Pfizer Inc PFE stock undervalued historicallyQuarterly Earnings Report & Proven Capital Preservation Tips - moha.gov.vn
Thousands Sue Pfizer Over Claims That Birth Control Caused Brain Tumors - iHeart
PFIZER INC : UBS withdraws its Sell rating - MarketScreener
Alert from law firm on Pfizer Depo-Provera MDL trial date withdrawn - MarketScreener
Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio - Bluefield Daily Telegraph
This Could Be Key to Pfizer's Turnaround in 2026 - Finviz
Bayer takes Pfizer and BioNTech to court over COVID vaccines - MarketScreener
Pfizer’s Scottish RSV Maternal Vaccine Study: What Investors Should Watch - TipRanks
Pfizer's Gandsman Takes Zeno Post - O'Dwyer's PR
Pfizer stock gains early as UBS starts coverage; Bayer mRNA lawsuit adds fresh risk - ts2.tech
Vitiligo Market Set for Robust Expansion Through 2034, DelveInsight Reports | Pfizer, Clinuvel, Inc., Clinuvel Pharmaceuticals, Bioniz Therapeutics, TAGCyx Biotech - The Globe and Mail
Pfizer needs more than obesity deal to drive growth post-2028, UBS says - Investing.com Canada
Bayer Sues Biontech and Pfizer Over Patents for Covid Vaccines - MarketScreener
Pfizer: 2026 Guidance Points To Continued Margin And Growth Pressure (NYSE:PFE) - Seeking Alpha
Bayer Targets Pfizer, Moderna, J&J For Covid Jab Royalties - Law360
Bayer sues COVID vaccine makers over mRNA technology - Reuters
December Social Media Round-Up—2025 Highlights, YaoPharma Co., Ltd. Global Collaboration, and More - Pfizer
Is Pfizer (PFE) Offering Value After Recent Share Price Weakness? - Yahoo Finance
Pfizer Stock Plot Twist: Is This Big Pharma OG a Secret Comeback Play or Total Trap? - AD HOC NEWS
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Pfizer invested in this Peninsula biotech startup. Now they've cut a potentially big drug deal - The Business Journals
Cartography Biosciences And Pfizer To Collaborate On The Discovery Of Tumor-Selective Antigens - TradingView — Track All Markets
Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens - Business Wire
Torray Investment Partners LLC Acquires 102,107 Shares of Pfizer Inc. $PFE - MarketBeat
Sulfasalazine Market Is Booming Worldwide 2026-2033 | Pfizer - openPR.com
Robeco Institutional Asset Management B.V. Has $290.44 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Phenobarbital Market See Incredible Growth 2025-2032 | Sanofi, Pfizer Inc., Novartis AG, H. Lundbeck A/S - openPR.com
Pfizer's Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
Gateway Investment Advisers LLC Lowers Stock Position in Pfizer Inc. $PFE - MarketBeat
Sleep Aids Market Booming with Rapid Growth Through 2033| Pfizer Inc., GSK plc, Sommetrics, Inc. - openPR.com
Pfizer’s 2026 Drug Price Reset Could Be A Game Changer For Pfizer (PFE) - simplywall.st
Pfizer (PFE) Stock: COVID-19 Revenue Decline Spurs Strategic Shift - parameter.io
Pfizer Inc. $PFE Position Cut by Commonwealth Equity Services LLC - MarketBeat
Pfizer (PFE) Plans Price Increases on About 80 Medicines Despite Broader Pricing Deals - Finviz
0.36%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):